Pharmacovigilance 2018 - 17th Pharmacovigilance 2018

Pharmacovigilance is uniquely placed to nurture sharing of good practice between industry representatives and seeking advice from regulators and inspectors as we all strive to improve the way we manage patient safety and comply with legislation.
Virtue Insight has worked close with Industry and Regulators to bring topics and speakers together with broad audiences in order to create stimulating and relevant discussion.
We are glad to announce the 17th Pharmacovigilance 2018 to be held on 15th November 2018 in Mumbai, India. It focuses on the advancements in Pharmacovigilance, Risk Management, and Drug Safety.
The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 17th Pharmacovigilance 2018 emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.
Why to attend?
With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive named recognition at this event. Renowned Speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are Hallmarks of this Conference.
It gives us immense pleasure in welcoming you to the 17th Pharmacovigilance 2018. I wish and pray that all our efforts will be beneficial to our industries and to our country at large
KEY THEMES DISCUSSED:-
Pharmacovigilance in 2020 - future horizons and efficiencies
Updates towards of legislation, policies, systems, technology, communication strategies and best practice in PV
Challenges for good pharmacovigilance practices for the generic industry. How to overcome them?
Importance of signal management for the generic industries
Importance of pharmacovigilance for the pharma industries in India
Focusing on the monitoring process of safety of medicines in India
Pharmacovigilance and risk management planning
Marketing authorization for medicines that do not have RMP
Discussing the key feature of benefit risk assessments from a regulatory perspective and how the patient is included in the discussion
Forming fundamental basis of regulatory decision making through benefit-risk assessments
How Brexit will impact pharmacovigilance in India
Any adverse impact on the rules, regulations and product registrations
Manual and medical devices reporting: Detecting and evaluating drug safety signals
Monitoring safety of medicative products during product life cycle
Automation/Data Processing/AI – Future of PV
Adverse event case reporting with the help of AI automation
Decreasing phase trials by implementing predictive analytics to impact patient safety
Current regulatory framework and expectations for good pharmacovigilance practices
Explanation on the GVP modules and newly revised GVP structures
Be part of a major networking opportunity